Full results from the positive Phase III KALOS and LOGOS trials published in The Lancet Respiratory Medicine showed AstraZeneca’s BREZTRI Aerosphere (budesonide ...
Unfortunately you've used all of your gifts this month. Your counter will reset on the first day of next month. KALOS and LOGOS were replicate confirmatory, randomised, double-blind, double-dummy, ...
Positive and clinically meaningful results from the Phase III KALOS and LOGOS trials for BREZTRIin patients with uncontrolled asthma published in The Lancet Respiratory Medicine Full results from the ...
(Alliance News) - NatWest beats annual earnings expectations and boosts shareholder returns, while AstraZeneca reports positive late-stage trial data for Breztri in asthma, as UK retail footfall ...
In the phase 3 KALOS and LOGOS trials, single-inhaler fixed-dose triple therapy Breztri Aerosphere significantly improved lung function and reduced severe exacerbation rates vs dual-combination ...
AstraZeneca AZN is scheduled to report fourth-quarter and full-year 2025 results on Feb. 10, before the opening bell. In the last reported quarter, the company delivered an earnings surprise of 4.39% ...
What fits in the overhead bin today may not tomorrow, according to a warning that has travelers rethinking how much confidence they can place in carry-on labels. In the clip, Schaler said that, “so ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results